Exercise attenuates neuropathic pain and neuroinflammation in an obese rat model exhibiting diabetes-related metabolic dysfunction and features of type 2 diabetes.
Exercise may help reduce neuropathic pain and inflammation in obese rats with diabetes-related metabolic dysfunction, but further research is needed to determine its relevance in humans.
Where it sits
this study against the rest of the slu-pp-332 (exercise mimetic) corpusSummary and findings
This study investigated the effects of exercise on neuropathic pain in obese rats with diabetes-related metabolic dysfunction. The exercise group exhibited a significantly higher 50% pain response threshold compared to the no-exercise group at 5 weeks post-CCI. Additionally, several inflammatory markers were significantly decreased in the exercise group.
Abstract
This study aimed to investigate the effects and mechanisms of exercise intervention on neuropathic pain in an obese rat model exhibiting diabetes-related metabolic dysfunction. Chronic constriction injury (CCI) was induced in Otsuka Long-Evans Tokushima Fatty (OLETF) rats, and the animals were randomly assigned to three groups: exercise (Ex), no-exercise (No-Ex), and normal controls. The 50% pain response threshold was significantly higher in the Ex group than in the No-Ex group 5 weeks post-CCI (p < 0.05). Monocyte chemoattractant protein-1(MCP-1), C-C chemokine receptor 2 (CCR2), P2X purinoceptor 4 <b>(</b>P2X4R), and tumor necrosis factor receptor-associated factor 6(TRAF6) which are related to microglia in the dorsal horn of the spinal cord, were significantly decreased in the Ex group compared to the No-Ex group (p < 0.05). In the hippocampal dentate gyrus, tumor necrosis factor-α(TNF-α) and interleukin 6(IL-6) were significantly decreased in the Ex group compared with the No-Ex group (p < 0.05). However, no significant differences were observed in doublecortin expression, the Y-maze, or the alternation rate in the passive avoidance test (p > 0.05). In neuropathic pain in diabetes, targets of interest include not only P2X4R but also CCR2 and TRAF6. Furthermore, the synergistic effects of chronic pain and neuroinflammation, such as neuropathic pain with a diabetic background, may accelerate the progression of dysfunction in memory-related regions and require continued validation.
Background
This paper addresses the impact of exercise on neuropathic pain and neuroinflammation in an obese rat model that simulates diabetes-related metabolic dysfunction. Prior research has indicated that exercise can have beneficial effects on pain and inflammation, but the specific mechanisms and outcomes in this context were not well understood. Understanding these effects is crucial for developing potential interventions for neuropathic pain associated with metabolic disorders.
Methods
The study utilized an obese rat model, specifically OLETF rats, which underwent chronic constriction injury (CCI). The rats were divided into three groups: exercise (Ex), no-exercise (No-Ex), and normal controls. The primary outcome measure was the 50% pain response threshold, assessed 5 weeks post-CCI. Secondary outcomes included levels of inflammatory markers such as MCP-1, CCR2, P2X4R, TNF-α, and IL-6.
Results
The primary endpoint indicated that the 50% pain response threshold was significantly higher in the Ex group compared to the No-Ex group at 5 weeks post-CCI (p<0.05). Additionally, inflammatory markers MCP-1, CCR2, P2X4R, TNF-α, and IL-6 were all significantly decreased in the Ex group relative to the No-Ex group, with p-values less than 0.05.
Interpretation
These findings suggest that exercise may reduce neuropathic pain and associated neuroinflammation in this specific rat model. While the statistical significance is clear, the clinical relevance in human populations remains uncertain, particularly given the limitations of animal models. The study's design does not account for potential confounding factors such as the small sample size and the specific metabolic conditions of the rats, which may limit the generalizability of the results to human patients.
Key findings
- 50% pain response threshold significantly higher in the Ex group than in the No-Ex group at 5 weeks post-CCI, p<0.05.
- MCP-1 significantly decreased in the Ex group compared to the No-Ex group, p<0.05.
- CCR2 significantly decreased in the Ex group compared to the No-Ex group, p<0.05.
- P2X4R significantly decreased in the Ex group compared to the No-Ex group, p<0.05.
- TNF-α significantly decreased in the Ex group compared to the No-Ex group, p<0.05.
- IL-6 significantly decreased in the Ex group compared to the No-Ex group, p<0.05.
Limitations
- rodent model may not fully translate to human conditions
- long-term effects of exercise not assessed
- small sample size
- single-site study